IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Patrys is a Public Company that generates the majority of its income from the Medical and Surgical Equipment Manufacturing industry. In 2024 the company generated total revenue of $1,394,000 including sales and other revenue. The exact number of employees for this organisation is not available. The Chief Executive Officer of Patrys is either not applicable or not available.The Chairman of Patrys is Mr Peter Christie whose official title is Non-Executive Chairman. Patrys Limited is a research company that utilises its proprietary deoxymab antibody technology platform in order to develop new therapies for the treatment of cancer. The company has two humanised forms of deoxymab 3E10 under development including two antibodies called PAT-DX1 and PAT-DX3.
Answer any industry question in minutes with our entire database at your fingertips.
Feed trusted, human-driven industry intelligence straight into your platform.
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
IBISWorld's research coverage on the Patrys Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Patrys Limited, trading as Patrys, operates under the ABN 97 123 055 363 and was incorporated on 08 December 2006. Patrys Limited trades on the Australian Securities Exchange under the ticker code ASX:PAB. Patrys Limited primarily operates in the Medical and Surgical Equipment Manufacturing industry in Australia.
The Key Personnel chapter outlines the principal leadership positions within Patrys Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
The Financials chapter presents Patrys Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which Patrys Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
The Competitor Benchmarking chapter includes a comparative assessment of Patrys Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
The Shareholders chapter provides a breakdown of the ownership structure of Patrys Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by Patrys Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
The History chapter presents a overview of Patrys Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Patrys Limited is a research company that utilises its proprietary deoxymab antibody technology platform in order to develop new therapies for the treatment of cancer. The company has two humanised forms of deoxymab 3E10 under development including two antibodies called PAT-DX1 and PAT-DX3.
Patrys Limited, trading as Patrys, is a Public Company that generates the majority of its income from the Medical and Surgical Equipment Manufacturing industry in Australia.
Murray Cod Australia Limited company is based at 385 Bourke Street, Melbourne, Victoria, Australia.
The Chief Executive of Patrys Limited is Peter Christie and the Chief Executive is Not Available.
In 2025, Patrys Limited generated total revenue of approximately $1.4 million.